Economic Forecasts and Performance Review slide image

Economic Forecasts and Performance Review

Credit Performance by Business Lines Q4/18 Q1/19 Q2/19 Q3/19 Q4/19 (As a % of Average Net Loans & PCLs on PCLs on PCLs on PCLs on Total PCLs on Total Total Total Total Impaired PCLs (adj.) Impaired Impaired Impaired PCLS Impaired PCLS PCLS PCLS Acceptances) Loans Loans Loans Loans (adj.) Loans Total Canadian Banking (%) 0.22 0.23 0.27 0.271 0.28 0.301 0.29 0.271 0.28 0.27 Total Canadian Banking ($MM) 188 198 229 233 233 252 256 240 255 247 Retail (%) 0.25 0.25 0.28 0.28 0.31 0.35 0.33 0.30 0.30 0.30 Retail ($MM) 181 179 201 202 220 245 242 218 226 227 Commercial (%) 0.06 0.15 0.21 0.231 0.09 0.061 0.10 0.161 0.20 0.14 Commercial ($MM) 7 19 28 31 13 7 14 22 29 20 Total International Banking (%) 1.20 1.051 1.23 1.281 1.29 1.301,2 1.36 1.241 1.26 1.341 Total International Banking ($MM) 4662 4122 451 470 472 4773 522 476 477 502 Retail (%) 2.38 2.21 2.33 2.36 2.36 2.352 2.48 2.28 2.34 2.44 Retail ($MM) 412 384 416 421 421 4193 462 425 429 448 Commercial (%) 0.071 (0.06)1 0.19 0.261 0.27 0.301,2 0.30 0.261 0.25 0.30 Commercial ($MM) 543 283 35 493 51 582,3 60 513 48 543 Global Banking and Markets (%) (0.07) (0.09)1 (0.01) (0.07) (0.02) (0.02) (0.01) (0.01) 0.05 0.02 Global Banking and Markets $MM) (17) (20)³ (1) (16) (5) (6) (2) (4) 12 43 Other ($MM) 1 (1) 1 _3 All Bank (%) All Bank ($MM) 0.42 637 0.391 590 0.47 0.471 0.49 0.511 0.52 0.481 0.49 0.501 679 688 700 722 776 713 744 753 1 Excludes provision for credit losses on debt securities and deposit with banks 2 On an adjusted basis; adjusted for Day 1 PCLs from acquisitions 3 Includes provision for credit losses on debt securities and deposit with banks of $nil in Canadian Banking (Q1/19: $2 million, Q2/19: -$1 million, Q3/19: -$1 million), -$3 million in International Banking (Q4/18: $41 million (impaired) and $40 million (total), Q1/19: $2 million, Q2/19: -$1 million, Q3/19: $1 million), -$1 million in Global Banking and Markets (Q4/18: $1 million) and $1 million in Other (Q1/19: -$1 million, Q2/19: $1 million) 53
View entire presentation